Status:
COMPLETED
Prospective Observational Epidemiologic Study of Maraviroc's Safety
Lead Sponsor:
ViiV Healthcare
Collaborating Sponsors:
Pfizer
Conditions:
Human Immunodeficiency Virus
Eligibility:
All Genders
18+ years
Brief Summary
The study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral ...
Detailed Description
All patients meeting the study eligibility criteria at participating sites will be invited to participate.
Eligibility Criteria
Inclusion
- Treatment experienced, HIV-1 infected patients
- 18 years or older
- Receive an approved assay for determination of HIV-1 tropism
Exclusion
- Pregnant or lactating
- Using CCR5 inhibitor other than maraviroc
Key Trial Info
Start Date :
March 31 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 14 2019
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT00665561
Start Date
March 31 2008
End Date
February 14 2019
Last Update
October 18 2022
Active Locations (269)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Services Center
Hobson City, Alabama, United States, 36201
2
AAC/Davis Clinic
Huntsville, Alabama, United States, 35801
3
Alabama Infectious Diseases Center
Huntsville, Alabama, United States, 35801
4
Office of Franco Antonio Felizarta MD
Bakersfield, California, United States, 93301